Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567177 · ClinicalTrials.gov registry record · Phase 4
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00567177 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 40 participants.
The verdict
NCT00567177, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.
Interventions
- DRUG Restasis, Refresh Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567177
The ClinicalTrials.gov registry entry for NCT00567177 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restasis, Refresh Plus is the first listed.
NCT00567177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567177 about?
NCT00567177 is a clinical study titled "Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease". We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.
What is the current status of trial NCT00567177?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2007-11. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00567177?
The interventions under investigation include: Restasis, Refresh Plus (DRUG).
Who is sponsoring clinical trial NCT00567177?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.